Member Info for crumbs

It's not clear is it... you would think they would have at least waited on ph3 results if it was about the vaccine not being thought worthy.....
To be honest I was surprised at the amounts of that particular vax that was pre ordered way back... a huge amount to my mind... I get the Scots manufacturing angle ...jobs etc but I always thought that's a lot to order for an unproven vax...

I do think there will be a bias towards the already proven vaxs now... having said that if a clear universal vax solution emerges I would think the GOV would back it especially if it was UK made...... The Covid cost bill is coming in now and it is going to be very costly to us all-tax rises and cost-cutting.... You would think a one off cheap jab that could protect for years would become very attractive

I wonder what the story behind the story is with that.... possibly our Gov at the moment only has plans for using Pfizer Astra and Moderna vaxs??.... Anyways its knocked over 30% off Valnevas value

Hope so :)

A universal Covid vaccine in trial is more than hope seeing as the pandemic that is causing much market turbulence is far from over and vaccines are still the best 'hope' especially ones that have the potential Covidty has...
we'll see.... the sp here doesn't much follow market trends it is not tied to commodity prices etc

I got so used to the sp post moditope announcement spike slow death spiral especially after 2015 AGM of doom that these are new waters lol and long may they flow

Obviously there are lots of other potential positive newsflow that may come and cause an sp jump Avidimab licensing deal/s glycan MaBs deal/s the potential now of the next-gen SCIBs..... the ph1/2 Covidity data ought to be pivotal there, glycan MaBs deal/s ....scancell surprises! The what is Zakari reveal... etc etc but most essential to me now is getting the 3 trials producing data via actual patients being dosed .... Lindy has a few quid to get herself booked into a nice Cape town hotel now:) come on team scancell lets be avin it!

What is of more interest to me (and probably all other holders) is how do we break out from it lol.... and defo not how do we crash below it .... I reckon Vulpes has played its part to keep this range with the diggle wiggles... they also played their part in stopping it going over 30p with their earlier wiggles too!

So how to break out and I think it would be a break out as looks to me as most hands are strong and long here a lot of tightly held shares.....
Dosing of patients in all trials will be a great step forwards but though probably being sp positive I don't think that will cause a breakout that would more come with the essential third party interest.... the Covidity gets taken on by CEPI type thing or better great ph1/2 data on Covidity arrives and in comes a pharma to take it through ph3 (it won't be going into one without a real big hitter or CEPI) ..... later down the line modi 1 goes 'mouse model' well that would be the dream but so long as sIPTM is proven up as a clinically effective route to Cancer treatment it would I reckon have a great sp effect and could be the entry point for a big partner/s

I'm happy to be treading this range though its a whole lot better than a hundred years of under 10p!

Be happy with today I was all set for the inevitable negative AIM reaction and primed for a sub 20p trade but the 20p support here is strong! ...I guess a lot of shares are in strong hands even more now lol All bodes well for excitement on positive newsflow
onwards to dosing patients now :)

And who knows maybe Lindy will treat the team with her deserved windfall they all deserve it

Must remember the BOD took pay cuts and Lindy will have had the busiest year of her Scancell career... I for one do not begrudge her a financial award and compared to some on AIM BODs!!!! crikey she is a saint... I've invested in her IP if her IP does the 'unrivalled' I'll be a happy investor she will be world-renown and not bad off at all Cancer will have been given the kicking of its life and Ruck will need a new calculator!.....

fi MM want to give me the sub 20p trade then someone sell on the bell ..... as I'll be well happy to get another 10-20% profit bargain :)

violin I have no doubt it'll be exploited.....It does not affect the way I view scancell though so... I should be ready to play the game as it were lol

You either look at it as people close to the CEO bought a large amount of shares off her at market value because they understand the value and as well as reaping a reward she also now has a greater incentive to see scancell succeed and share in the financial rewards
or the CEO inventor is cashing in as she knows her products are cack .....

She may drop a bomb RNS on market tomorrow and show market savvy genius.... or MM will be desperate for the first sell of the day with a spread that marks the sp right down.... could be a good trade op as all recent sub 20p ones have been and you never know another Diggle wiggle could pop up.

Could be ivy, I see it as bullish too but wouldn't be surprised if market fun and games means sub 20p action and potential diggle wiggle we'll see

It'd be funny if the private individual turned out to be Evans

Plus she must have convinced the private individual buyer and the ii as to her reasons... so to me nowt to see here however AIM and mischief markers will no doubts try to make something of it :)

Yeah to Lindy's house as drinks will be on her

Good to see no dumping onto the open market

67% of their ordinary share pool invested in scancell .... yeah pretty much like mine lol ... though I reckon they will through return necessity cash in chunks of theirs before I do mine :)

There's a funny thing Modernas Mcap is $172 billion Mercks $190 billion...how can that even be!! Ruck?

A guess a cheeky observation about IP's and values and their translation into Mcaps...... It is not a clear-cut thing as in it certainly cannot all be about revenues as Mercks is much higher than Modernas, market sentiment plays a huge part.

'The world still needs more — and better — Covid-19 vaccines. But a major hurdle stands in the way of the development of new vaccines, as well as the critical studies needed to determine the best way to use these important tools, the Coalition for Epidemic Preparedness Innovations (CEPI) warned in a letter published Tuesday in the journal Nature.'

https://www.statnews.com/2021/09/07/cepi-warns-of-major-hurdle-to-developing-new-covid-19-vaccines-boosters/
“We’re stuck with the vaccines we have unless we can move forward.”

I think whenever it involves Lindy Durrant you can say it involves scancell :) especially now the Mabs/Avidimab are in-house... anyways just something to watch as Continuum are on the move.... so we get to see exactly what it is they plan to take into trial in the coming months ....

BTW it seems they will be taking the TCR route and in making Br Bent their CEO they mean business! Dr Hull is not quite redmile but he is loaded enough since selling some motors to maybe get some proof of concept data.....

I remember back in day when Lindy did the Calculus presentation not long after collaborating with BioNTech around TCR she doesn't much like the route in as much as she thought and maybe still does why bother with all the expense and complication when a simple moditope vaccine can do all the work......... However if she is seeing Cancer patient samples proving up the science around moditope that will be yet more validation of sIPTM as a new mechanism route for cancer therapeutic..... maybe some cancer patients immune systems kick start a moditope response by themselves, therefore, becoming super survivours.